- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Areva’s Nuclear Program Still a Priority Despite Restructuring Plan
Mining Weekly reported that despite Areva Group’s extensive restructuring initiatives, the company’s proposed nuclear program in South Africa remains a key target market.
Mining Weekly reported that despite Areva Group’s extensive restructuring initiatives, the company’s proposed nuclear program in South Africa remains a key target market. Areva has opted to cut costs moving forward and will be far more selective in the market opportunities it pursues, however, its plan for 9,600 megawatt nuclear build program in South Africa remains a priority that won’t be affected by restructuring.
As quoted in the market news:
Areva has announced plans to cut costs by €1-billion by 2017, dispose of non-core businesses and strengthen relations with State-owned utility EDF in an effort to realign the business to a weaker-than-anticipated outlook for the global nuclear market.
The company, which is also dealing with several “difficult projects” and lower prices and demand for enriched uranium, expects the global installed nuclear base to grow by only 2.5% a year between now and 2030.
The project pipeline is being re-prioritized, with Areva indicating that it will be far more selective in the market opportunities it pursues outside of Europe and China, with the latter expected to have the largest installed nuclear base by 2030, ahead of the US and France.
However, Areva South Africa MD Dr Yves Guenon confirms that South Africa, which is considering a 9 600 MW nuclear build program, remains a key target market and that the restructuring will not fundamentally alter its bid package, should the country eventually launch a procurement process.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.